Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Exercise and Ibuprofen in Bipolar Depression
NCT06088732Phase 2Recruiting
- Start
- Mar 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ibuprofen in bipolar disorder (BD) (4 arms). Primary endpoints: Interleukin-6 and Neural Response to Reward Anticipation. Started Mar 2024; status: recruiting.
02
Drugs
ibuprofen
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT06088732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06088732.